Guixiang Lv

1.0k total citations
26 papers, 802 citations indexed

About

Guixiang Lv is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Guixiang Lv has authored 26 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Cancer Research and 9 papers in Biomedical Engineering. Recurrent topics in Guixiang Lv's work include Nanoplatforms for cancer theranostics (8 papers), MicroRNA in disease regulation (6 papers) and Photodynamic Therapy Research Studies (5 papers). Guixiang Lv is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), MicroRNA in disease regulation (6 papers) and Photodynamic Therapy Research Studies (5 papers). Guixiang Lv collaborates with scholars based in China, United States and Japan. Guixiang Lv's co-authors include Xu Gao, Zheng Hu, Ning Ma, Yu Qiao, Wenwu Cao, Chaoxia Zou, Changqing Xu, Jianfeng Jin, Dong Han and Ya Xu and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Chemical Engineering Journal.

In The Last Decade

Guixiang Lv

24 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guixiang Lv China 14 513 430 116 80 77 26 802
Tian Lin China 11 492 1.0× 336 0.8× 70 0.6× 52 0.7× 92 1.2× 23 716
Dexiao Yuan China 18 408 0.8× 255 0.6× 75 0.6× 78 1.0× 165 2.1× 26 753
Xiaoguang Sun China 13 351 0.7× 317 0.7× 77 0.7× 42 0.5× 117 1.5× 19 756
Wenxiao Jiang China 16 463 0.9× 281 0.7× 61 0.5× 61 0.8× 120 1.6× 29 819
Huiqin Zhuo China 18 478 0.9× 280 0.7× 58 0.5× 26 0.3× 68 0.9× 44 762
Xuan Su China 16 469 0.9× 240 0.6× 45 0.4× 40 0.5× 114 1.5× 57 799
Xiaoqing Cao China 15 581 1.1× 472 1.1× 45 0.4× 25 0.3× 91 1.2× 30 901
Xigan He China 12 459 0.9× 327 0.8× 36 0.3× 46 0.6× 114 1.5× 28 706
Huan Zeng China 17 654 1.3× 509 1.2× 49 0.4× 56 0.7× 67 0.9× 41 943
Hongyi Jiang China 15 308 0.6× 179 0.4× 68 0.6× 31 0.4× 76 1.0× 52 642

Countries citing papers authored by Guixiang Lv

Since Specialization
Citations

This map shows the geographic impact of Guixiang Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guixiang Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guixiang Lv more than expected).

Fields of papers citing papers by Guixiang Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guixiang Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guixiang Lv. The network helps show where Guixiang Lv may publish in the future.

Co-authorship network of co-authors of Guixiang Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Guixiang Lv. A scholar is included among the top collaborators of Guixiang Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guixiang Lv. Guixiang Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Yi, Guixiang Lv, Zheng Hu, et al.. (2025). Thermosensitive hydrogel delivering a self-reinforced dual cascade nanoreactor for synergistic cuproptosis induction and immune microenvironment remodeling. Chemical Engineering Journal. 522. 167867–167867. 1 indexed citations
2.
Li, J, et al.. (2025). Revealing Lingonberry’s Neuroprotective Potential in Alzheimer’s Disease Through Network Pharmacology and Molecular Docking. International Journal of Molecular Sciences. 26(5). 2363–2363.
3.
Liu, Yi‐Chun, Pingping Xue, Yinghua Qi, et al.. (2024). Cold scissors ploughing technique versus electrosurgical excision for hysteroscopic adhesiolysis: a multicenter randomized controlled trial. International Journal of Surgery. 111(2). 2002–2009.
4.
Cheng, Qian, Zhiyi Wu, Yuxi Zhang, et al.. (2024). Comprehensive analysis of consensus molecular subtypes for ovarian cancer from bulk to single-cell perspectives. Journal of Biological Chemistry. 300(9). 107710–107710. 1 indexed citations
5.
Li, Jia, et al.. (2023). Antitumor Effects of Pegylated Zinc Protoporphyrin-Mediated Sonodynamic Therapy in Ovarian Cancer. Pharmaceutics. 15(9). 2275–2275. 3 indexed citations
6.
Zhang, Zhicheng, Xiaochen Jiang, Kai Li, et al.. (2023). KLF7 promotes colon adenocarcinoma progression through the PDGFB signaling pathway. International Journal of Biological Sciences. 20(1). 387–402. 1 indexed citations
7.
Lv, Guixiang, Zhihui Dong, Ning Ma, et al.. (2022). Precision Killing of Sinoporphyrin Sodium-Mediated Photodynamic Therapy against Malignant Tumor Cells. International Journal of Molecular Sciences. 23(18). 10561–10561. 2 indexed citations
8.
Sun, Yi, Guixiang Lv, Feng Qin, et al.. (2021). Sinoporphyrin sodium mediated sonodynamic therapy generates superoxide anions under a hypoxic environment. New Journal of Chemistry. 45(40). 18994–19001. 2 indexed citations
9.
Sun, Yi, Guixiang Lv, Feng Qin, et al.. (2021). Involvement of hydrogen peroxide in sonodynamical effect with sinoporphyrin sodium in hypoxic situation. Free Radical Research. 55(9-10). 958–969. 2 indexed citations
10.
Zhang, He, Chendan Zou, Dayong Wang, et al.. (2020). CPEB3-mediated MTDH mRNA translational suppression restrains hepatocellular carcinoma progression. Cell Death and Disease. 11(9). 792–792. 34 indexed citations
11.
Zhang, Yongjian, He Zhang, Chao Zhan, et al.. (2018). CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 37(1). 46–46. 57 indexed citations
12.
Liang, Huan, Hui Huang, Ying Liu, et al.. (2017). Effect of iron on cholesterol 7α-hydroxylase expression in alcohol-induced hepatic steatosis in mice. Journal of Lipid Research. 58(8). 1548–1560. 15 indexed citations
13.
Hu, Zheng, Guixiang Lv, Yongning Li, et al.. (2016). Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound. Journal of Experimental & Clinical Cancer Research. 35(1). 71–71. 47 indexed citations
14.
Chen, Xiaohong, Shi-Yao Wei, Qingfang Zhang, et al.. (2016). Overexpression of Heme Oxygenase-1 Prevents Renal Interstitial Inflammation and Fibrosis Induced by Unilateral Ureter Obstruction. PLoS ONE. 11(1). e0147084–e0147084. 50 indexed citations
15.
Hu, Zheng, Haixia Fan, Guixiang Lv, et al.. (2015). 5-Aminolevulinic acid-mediated sonodynamic therapy induces anti-tumor effects in malignant melanoma via p53-miR-34a-Sirt1 axis. Journal of Dermatological Science. 79(2). 155–162. 52 indexed citations
16.
Lv, Guixiang, Zheng Hu, Yi Tie, et al.. (2014). MicroRNA-451 regulates activating transcription factor 2 expression and inhibits liver cancer cell migration. Oncology Reports. 32(3). 1021–1028. 48 indexed citations
17.
Qiao, Yu, Ning Ma, Xidi Wang, et al.. (2011). MiR-483-5p controls angiogenesis in vitro and targets serum response factor. FEBS Letters. 585(19). 3095–3100. 63 indexed citations
18.
Zhou, Lingyun, Ying Liu, Chaoxia Zou, et al.. (2010). The Effect of the Gly139His, Gly143His, and Ser142His Mouse Heme Oxygenase‐1 Mutants on the HO Reaction In Vivo and In Vitro. The Anatomical Record. 294(1). 112–118. 11 indexed citations
19.
Ma, Ning, Xidi Wang, Yu Qiao, et al.. (2010). Coexpression of an intronic microRNA and its host gene reveals a potential role for miR-483-5p as an IGF2 partner. Molecular and Cellular Endocrinology. 333(1). 96–101. 75 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026